LivaNova
Clinical trials sponsored by LivaNova, explained in plain language.
Medical device company focused on cardiac surgery and neuromodulation.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Can a nerve stimulator beat tough depression? new study tracks Long-Term results
Disease control Recruiting nowThis study follows 500 people with treatment-resistant depression who receive Vagus Nerve Stimulation (VNS) Therapy, an implanted device that sends electrical pulses to the vagus nerve. Researchers will track how many patients see a 50% or greater improvement in depression scores…
Sponsor: LivaNova • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a neck implant lift severe depression?
Disease control Recruiting nowThis study tests a device that stimulates the vagus nerve in the neck to treat depression that hasn't responded to other treatments. About 6,800 people will either get the active implant or a sham device. Researchers will track depression symptoms over 12 months to see if the sti…
Sponsor: LivaNova • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC